Brief: Agilon Health Q2 Revenue USD 1,500 Million Vs. IBES Estimate USD 1,560 Million
Aug 06 (Reuters) - Agilon Health Q2 net income USD -31 million vs. IBES estimate USD -31.5 million. * Q2 adjusted EBITDA USD -3 million vs. IBES estimate USD -8.42 million
Recent news on Agilon Health
See all newsU.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics